US 7923004
4-ethynyl pyrazole derivative compounds and methods for treatment of HCV
granted A61PA61P31/12A61P31/18
Quick answer
US patent 7923004 (4-ethynyl pyrazole derivative compounds and methods for treatment of HCV) held by XTL BIOPHARMACEUTICALS LTD. expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- XTL BIOPHARMACEUTICALS LTD.
- Grant date
- Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P31/12, A61P31/18, A61P43/00